JY
BLRX

Jeff Yass’s BioLineRX BLRX Stock Holding History

Jeff Yass’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.8K Buy
+30,911
New +$89.6K ﹤0.01% 12527
2025
Q3 		– Sell
-11,098
Closed -$44.5K – 12424
2025
Q2 		$50.7K Buy
+11,098
New +$41K ﹤0.01% 12109
2025
Q1 		– Sell
-2,180
Closed -$18.5K – 12505
2024
Q4 		$18.5K Buy
2,180
+1,729
+383% +$25.5K ﹤0.01% 11928
2024
Q3 		$9.67K Sell
451
-2,504
-85% -$68.8K ﹤0.01% 11727
2024
Q2 		$66.9K Sell
2,955
-2,168
-42% -$58.2K ﹤0.01% 11273
2024
Q1 		$230K Buy
5,123
+1,873
+58% +$94K ﹤0.01% 10304
2023
Q4 		$204K Sell
3,250
-2,683
-45% -$166K ﹤0.01% 10643
2023
Q3 		$432K Buy
5,933
+3,831
+182% +$257K ﹤0.01% 8574
2023
Q2 		$134K Buy
+2,102
New +$116K ﹤0.01% 10682
2022
Q2 		– Sell
-875
Closed -$60K – 12904
2022
Q1 		$60K Sell
875
-881
-50% -$61.4K ﹤0.01% 12223
2021
Q4 		$143K Sell
1,756
-186
-10% -$19.4K ﹤0.01% 11844
2021
Q3 		$212K Buy
+1,942
New +$230K ﹤0.01% 11362
2019
Q2 		– Sell
-128
Closed -$33K – 10220
2019
Q1 		$33K Sell
128
-78
-38% -$22.7K ﹤0.01% 8542
2018
Q4 		$54K Buy
+206
New +$99.2K ﹤0.01% 8455
2018
Q3 		– Sell
-180
Closed -$98K – 9224
2018
Q2 		$98K Buy
+180
New +$95.6K ﹤0.01% 9048
2017
Q3 		– Sell
-247
Closed -$126K – 8818
2017
Q2 		$126K Sell
247
-2,157
-90% -$1.11M ﹤0.01% 8577
2017
Q1 		$1.39M Buy
+2,404
New +$1.55M ﹤0.01% 4441
2016
Q4 		– Sell
-81
Closed -$56K – 9569
2016
Q3 		$56K Buy
+81
New +$43.2K ﹤0.01% 8091
2016
Q2 		– Sell
-65
Closed -$40K – 8537
2016
Q1 		$40K Buy
+65
New +$40.8K ﹤0.01% 8711

Other funds holding BLRX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
BCV
Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jeff Yass's BLRX Position: Q2 2026 in Review

Jeff Yass opened a new position in BioLineRX (BLRX) in Q2 2026: 30,911 shares worth $95.8K. The stake represents ﹤0.01% of the portfolio and ranks #12527 among its holdings. This is a return to the name: Jeff Yass previously reported a position in BLRX as recently as Q2 2025.

Jeff Yass first reported a position in BLRX in Q1 2016 and has held it in 19 quarters since. The position peaked at $1.39M in Q1 2017. 14 funds tracked by Wall St. Rank hold BLRX as of Q2 2026.

  • Jeff Yass held 30,911 shares of BioLineRX worth $95.8K as of Q2 2026.
  • BioLineRX was a new Jeff Yass position in Q2 2026.
  • BioLineRX made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12527 holding.
  • Jeff Yass first reported a position in BioLineRX in Q1 2016 and has held it in 19 quarters since.
  • Jeff Yass's BioLineRX position peaked at $1.39M in Q1 2017.
  • 14 funds tracked by Wall St. Rank held BioLineRX as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.